Reduced baroreflex sensitivity and pulmonary dysfunction in alcoholic cirrhosis: Effect of hyperoxia

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 3, 2010, Pages

  Møller, Søren ^a   Iversen, Jens S ^b   Krag, Aleksander ^a,c   Bie, Peter ^d   Kjær, Andreas ^e   Bendtsen, Flemming ^a,c  

^a HVIDOVRE HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bioactive substances; Cardiovascular regulation; Hyperoxia; Lung function; Portal hypertension

Indexed keywords

OXYGEN; ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; NORADRENALIN; RENIN;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD PRESSURE VARIABILITY; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEART RATE; HUMAN; HYPEROXIA; LUNG ALVEOLUS OXYGEN TENSION; LUNG DISEASE; MALE; OXYGEN BREATHING; PORTAL HYPERTENSION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SCORING SYSTEM; TIME SERIES ANALYSIS; AGED; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

AGED; ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BAROREFLEX; CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; HUMANS; HYPEROXIA; LIVER CIRRHOSIS, ALCOHOLIC; LUNG DISEASES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NOREPINEPHRINE; OXYGEN; RENIN;

EID: 77957008083     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00078.2010     Document Type: Article

References (52)

1. Aller R, Moya JL, Moreira V, Garcia-Lledo A, Sanroman AL, Paino C, Boixeda D. Diagnosis and grading of intrapulmonary vascular dilatation in cirrhotic patients with contrast transesophageal echocardiography. J Hepatol 31: 1044-1052, 1999.
2. Arranz CT, Chirico M, Costa MA, Demartini A, Carnero B, Lemberg A, Balaszczuk AM. Evaluation of autonomic function and baroreflex sensitivity in cirrhotic patients with portal hypertension. Med Sci Res 25: 193-195, 1997.
3. Barron HV, Alam I, Lesh MD, Strunk A, Bass NM. Autonomic nervous system tone measured by baroreflex sensitivity is depressed in patients with end-stage liver disease. Am J Gastroenterol 94: 986-989, 1999.
4. Bernardi M, Domenicali M. The renin-angiotensin-aldosterone system in cirrhosis. In: Ascites and Renal Dysfunction in Liver Disease, edited by Ginés P, Arroyo V, Rodes J, and Schrier RW. Malden, MA: Blackwell, 2005, p. 43-54.
5. Bie P, Sandgaard NC. Determinants of the natriuresis after acute, slow sodium loading in conscious dogs. Am J Physiol Regul Integr Comp Physiol 278: R1-R10, 2000.
6. Dümcke CW, Møller S. Autonomic dysfunction in cirrhosis and portal hypertension. Scand J Clin Lab Invest 68: 437-447, 2008.
7. Fallon MB. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome. J Clin Gastroenterol 39: S138-S142, 2005.
8. Fallon MB, Abrams GA. Pulmonary dysfunction in chronic liver disease. Hepatology 32: 859-865, 2000.
9. Frith J, Newton JL. Autonomic dysfunction in chronic liver disease. Liver Int 29: 483-489, 2009.
10. Genovesi S, Prata Pizzala DM, Pozzi M, Ratti L, Milanese M, Vincenti A, Stella A, Mancia G. Baroreceptor sensitivity and baroreceptor effectiveness index in cirrhosis: the relevance of hepatic venous pressure gradient. Liver Int 30: 232-239, 2009.
11. Gulli G, Claydon VE, Slessarev M, Zenebe G, Gebremedhin A, Rivera-Ch M, Appenzeller O, Hainsworth R. Autonomic regulation during orthostatic stress in highlanders: comparison with sea-level residents. Exp Physiol 92: 427-435, 2007.
12. Halliwill JR, Minson CT. Effect of hypoxia on arterial baroreflex control of heart rate and muscle sympathetic nerve activity in humans. J Appl Physiol 93: 857-864, 2002.
13. Hansen S, Møller S, Bendtsen F, Jensen G, Henriksen JH. Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic changes. J Hepatol 47: 373-380, 2007.
14. Henriksen JH, Bendtsen F, Hansen EF, Møller S. Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTC) in patients with cirrhosis. J Hepatol 40: 239-246, 2004.
15. Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Møller S. Arterial compliance in patients with cirrhosis. High stroke volume/pulse pressure ratio as an index of elevated arterial compliance. Am J Physiol Gastrointest Liver Physiol 280: G584-G594, 2001.
16. Henriksen JH, Gøetze JP, Fuglsang S, Christensen E, Bendtsen F, Møller S. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 52: 1511-1517, 2003.
17. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule. Hepatology 43: S121-S131, 2006.
18. Koshy A, Moreau R, Cerini R, Roulot D, Bacq Y, Hadenque A, Lebrec D. Effects of oxygen inhalation on tissue oxygenation in patients with cirrhosis. J Hepatol 92: 240-245, 1989.
19. Laffi G, Lagi A, Cipriani M, Barletta G, Bernardi L, Fattorini L, Melani L, Riccardi D, Bandinelli G, Mannelli M, Lavilla G, Gentilini P. Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. Hepatology 24: 1063-1067, 1996.
20. Luo B, Liu L, Tang L, Zhang J, Ling Y, Fallon MB. ET-1 and TNF-α in HPS: analysis in prehepatic portal hypertension and biliary and non- biliary cirrhosis in rats. Am J Physiol Gastrointest Liver Physiol 286: G294-G303, 2004.
21. Malpas SC. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol Heart Circ Physiol 282: H6-H20, 2002.
22. Møller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut 57: 268-278, 2008.
23. Moreau R, Roulot D, Braillon A, Gaudin C, Hadengue A, Bacq Y, Lebrec D. Low dose of nitroglycerin failed to improve splanchnic hemodynamics in patients with cirrhosis: evidence for an impaired cardiopulmonary baroreflex function. Hepatology 10: 93-97, 1989.
24. Møller S, Becker U, Schifter S, Abrahamsen J, Henriksen JH. Effect of oxygen inhalation on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 25: 316-328, 1996.
25. Møller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 109: 1917-1925, 1995.
26. Møller S, Bendtsen F, Henriksen JH. Determinants of the renin-angiotensin- aldosterone system in cirrhosis with special emphasis on the central blood volume. Scand J Gastroenterol 41: 451-458, 2006.
27. Møller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 87: 9-15, 2002.
28. Møller S, Henriksen JH. The systemic circulation in cirrhosis. In: Ascites and Renal Dysfunction in Liver Disease, edited by Gines P, Arroyo V, Rodes J, and Schrier RW. Malden, MA: Blackwell, 2005, p. 139-155.
29. Møller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut 57: 268-278, 2008.
30. Møller S, Henriksen JH, Bendtsen F. Central and noncentral blood volumes in cirrhosis. Relation to anthropometrics and gender. Am J Physiol Gastrointest Liver Physiol 284: G970-G979, 2003.
31. Møller S, Hillingsø J, Christensen E, Henriksen JH. Arterial hypoxaemia in cirrhosis: fact or fiction? Gut 42: 868-874, 1998.
32. Møller S, Iversen JS, Henriksen JH, Bendtsen F. Reduced baroreflex sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems. Am J Physiol Heart Circ Physiol 292: H2966-H2972, 2007.
33. Møller S, Krag A, Henriksen JH, Bendtsen F. Pathophysiological aspects of pulmonary complications of cirrhosis. Scand J Gastroenterol 42: 419-427, 2007.
34. Møller S, Krag A, Madsen JL, Henriksen JH, Bendtsen F. Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension. Liver Int 29: 1528-1537, 2009.
35. Møller S, Nørgaard A, Henriksen JH, Frandsen E, Bendtsen F. Effects of tilting on central hemodynamics and homeostatic mechanisms in cirrhosis. Hepatology 40: 811-819, 2004.
36. Møller S, Wiinberg N, Henriksen JH. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 22: 88-95, 1995.
37. Newton JL, Allen J, Kerr S, Jones DE. Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis. Liver Int 26: 197-202, 2006.
38. Patakas D, Louridas G, Kakavelas E. Reduced baroreceptor sensitivity in patients with chronic obstructive pulmonary disease. Thorax 37: 292-295, 1982. (Pubitemid 12108482)
39. Robbe HW, Mulder LJ, Ruddel H, Langewitz WA, Veldman JB, Mulder G. Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension 10: 538-543, 1987.
40. Roche F, Reynaud C, Garet M, Pichot V, Costes F, Barthelemy JC. Cardiac baroreflex control in humans during and immediately after brief exposure to simulated high altitude. Clin Physiol Funct Imaging 22: 301-306, 2002.
41. Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome - a liver-induced lung vascular disorder. N Engl J Med 358: 2378-2387, 2008.
42. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 24: 861-880, 2004.
43. Sagawa S, Torii R, Nagaya K, Wada F, Endo Y, Shiraki K. Carotid baroreflex control of heart rate during acute exposure to simulated altitudes of 3,800 m and 4,300 m. Am J Physiol Regul Integr Comp Physiol 273: R1219-R1223, 1997.
44. Sevre K, Bendz B, Hanko E, Nakstad AR, Hauge A, Kasin JI, Lefrandt JD, Smit AJ, Eide I, Rostrup M. Reduced autonomic activity during stepwise exposure to high altitude. Acta Physiol Scand 173: 409-417, 2001.
45. Tsai MH. Splanchnic and systemic vasodilatation: the patient. J Clin Gastroenterol 41: S266-S271, 2007.
46. Veglio F, Melchio R, Calva S, Rabbia F, Gallo V, Melino P, Mengozzi G, Mulatero P, Martini G, Riva F, Chiandussi L. Noninvasive assessment of spontaneous baroreflex sensitivity in patients with liver cirrhosis. Liver 18: 420-426, 1998.
47. Vogelsang TW, Jensen RJ, Hesse B, Kjaer A. BNP cannot replace gated equilibrium radionuclide ventriculography in monitoring of anthracycline-induced cardiotoxity. Int J Cardiol 124: 193-197, 2008.
48. Wong F. Cirrhotic cardiomyopathy. Hepatol Int 3: 294-304, 2009.
49. Yigit IP, Hacievliyagil SS, Seckin Y, Oner RI, Karincaoglu M. The relationship between severity of liver cirrhosis and pulmonary function tests. Dig Dis Sci 53: 1951-1956, 2008.
50. Ytting H, Henriksen JH, Fuglsang S, Bendtsen F, Møller S. Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis. J Hepatol 43: 637-644, 2005.
51. Zambruni A, trevisani F, Caraceni P, Bernardi M. Cardiac electro-physiological abnormalities in patients with cirrhosis. J Hepatol 44: 994-1002, 2006.
52. Zambruni A, Trevisani F, Di Micoli A, Savelli F, Berzigotti A, Bracci E, Caraceni P, Domenicali M, Felline P, Zoli M, Bernardi M. Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. J Hepatol 48: 415-421, 2008.